Effects of Science Intervention Service on Advanced Age Patients with Gestational Diabetes Mellitus
WANG Wei-boa, JIANG Shu-minb, LI Chun-qingc, LI Huid, LIU Xinb
a. Department of Pharmacy, b. Department of Nutriology, c. Department of Endocrinology, d. Department of Quality Control, Dongying People′s Hospital, Dongying 257091, China
Abstract：OBJECTIVE To explore the clinical effect of individualized guidance on the outpatient service of elderly patients with gestational diabetes mellitus (GDM). METHODS A prospective randomized controlled tria was carried out,totally 90 cases of elderly patients with GDM were divided into the intervention group(45 cases) and the control group (45 cases). In the intervention group, pharmacists and nutritionists were combined for individualized guidance of pharmacy and nutrition, while the control group had no individualized guidance of pharmacy and nutrition. The fasting blood glucose(FPG), 2 h postprandial blood glucose(2hPG),medication compliance and adverse drug reactions were compared between the two groups. RESULTS The FPG, 2hPG, HbA1C, blood glucose compliance index,medication compliance of the intervention group were better than the control group(P＜0.05). The adverse drug reactions in the intervention group had 1 case of hypoglycemia. The control group had 5 cases of adverse drug reactions,including 3 cases of hypoglycemia,1 case of induration at injection site and 1 case of skin rash(P＜0.05). The incidence of polyhydramnios, cesarean section, premature delivery and macrosomia of the intervention group were better than the control group(P＜0.05). CONCLUSION Individualized guidance can improve the FFG,PFG,HbA1C and medication compliance of GDM patients, reduce the occurrence of adverse drug reactions and maternal and infant complications.
王维波, 姜淑敏, 李春青, 李慧, 刘欣. 高龄妊娠期糖尿病患者个体化指导研究[J]. 中国药学杂志, 2020, 55(22): 1895-1898.
WANG Wei-bo, JIANG Shu-min, LI Chun-qing, LI Hui, LIU Xin. Effects of Science Intervention Service on Advanced Age Patients with Gestational Diabetes Mellitus. Chinese Pharmaceutical Journal, 2020, 55(22): 1895-1898.
KOIVUSALO S B, RÖNÖ K, KLEMETTI M M, et al. Gestational diabetes mellitus can be prevented by lifestyle intervention: the finnish gestational diabetes prevention study (RADIEL):a randomized controlled trial[J]. Diabetes Care, 2016, 39(1):24-30.
[2]
Chinese Diabetes Societ. Chinese practice guidelines of type 2 diabetes (2017)[J]. Chin J Diabetes Mel(中华糖尿病杂志), 2018, 10(1):4-67.
[3]
XIE X, GOU W L. Obstetrics and Gynecology(妇产科学)[M]. Vol 8.Beijing: People′s Medical Publishing House, 2013: 75-79.
[4]
Society of Obstetricians and Gynaecologists of Canada. Guideline No. 393-diabetes in pregnancy[J]. J Obstet Gynaecol Can, 2019, 41(12):1814-1825.
[5]
SUN Z Q. Medical Statistics(医学统计学)[M]. 2nd Ed. Beijing: People′s Health Publishing House, 2002.
[6]
GUO H J, JIANG M F, LIU J H, et al. Clinical effects of pharmaceutical services on patients with gestational diabetes mellitus[J]. Chin Hosp Pharm J(中国医院药学杂志), 2017, 37(24):2500-2504.
[7]
YANG H, GUO C L, YUAN X J, et al. The effect of personalized health education on the drug compliance and cognitive level of pregnant women with gestational diabetes[J]. Chin J Mod Drug Appl(中国现代药物应用), 2015, 9(19):268-269.
[8]
MORISKY D E, ANG A, KROUSEL-WOOD M, et al. Predictive validity of a medication adherence measure in an outpatients setting[J]. J Clin Hypertens, 2008, 10(5):348-354.
[9]
CLIFFORD S, PEREZ-NIEVES M, SKALICKY A M, et al. A systematic literature review of methodologies used to assess medication adherence in patients with diabetes[J]. Curr Med Res Opin,2014, 30(6):1071-1085.
[10]
Chinese Medical Association Diabetes Credit Union, Chinese Physicians Association Of Nutrition Physicians Professional Committee. Guide to nutritional treatment of diabetes medicine in China (2013) [J]. Chin J Diabetes Mel(中华糖尿病杂志), 2015, 7(2):73-88.
[11]
State Council. Opinions of the State Council on the implementation of the healthy China initiative (China Development Agency No.13 of 2019)[EB/OL]. (2019-07-15)[2020-06-11]. http://www.gov.cn/zhengce/content/2019-07/15/content_5409492.htm.
[12]
GENERAL OFFICE OF THE STATE COUNCIL. General Office of the State Council issued a circular on the key tasks for deepening the reform of the medical and health care system in 2019[EB/OL]. Beijing: 2019 (2019-06-04) [2020-07-23]. http://www.gov.cn/zhengce/content/2019-06/04/content_5397350.htm.
[13]
GUAN H, SHANG L X. Status of the prevalence of gestational diabetes[J]. Chin J Pract Gynecol Obstet(中国实用妇科与产科杂志), 2015, 31(1):91-94.
[14]
LIU Z, AO D, YANG H X, et al. Gestational weight gain and risk of gestational diabetes mellitus among Chinese women[J]. Chin Med J(Engl), 2014, 127(7):1255-1260.
[15]
HARTLING L, DRYDEN D M, GUTHRIE A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and Meta-analysis for the US Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of research[J]. Ann Intern Med, 2013, 159(2):123-129.
[16]
WANG W B, LI Z Q, WANG J Y, et al. Effects of pharmaceutical science intervention service in type 2 diabetes patients with hypertension[J]. J China Pharm(中国药房), 2019, 22(8):1464-1467.
[17]
LI Q Z, LI W, LAN L, et al. A prospective randomized controlled study of chronic disease management led by endocrinology clinical pharmacists in patients with type 2 diabetes[J]. Chin Pharm J(中国药学杂志), 2019, 54(7):588-591.
[18]
ANDREIA D S, ROSSANA P V, THATIANNET C T, et al. Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus[J]. Diabetes Res Clin Pract, 2010, 88(1):81-86.
2020, Vol. 55 
